Showing results (321-330 of 363) with videos related to
Sort By:
Pageof 37
Iranian Journal of Pharmaceutical Research : IJPR|August 18, 2020
Effect of Bedtime Melatonin Administration in Patients with Type 2 Diabetes: A Triple-Blind, Placebo-Controlled, Randomized TrialAmir Farrokhian, Maryam Tohidi, Noushin Sadat Ahanchi, et al.European Journal of Nutrition|March 29, 2022
Improvement of glycemic indices by a hypocaloric legume-based DASH diet in adults with type 2 diabetes: a randomized controlled trialSomayeh Hosseinpour-Niazi, Parvin Mirmiran, Farzad Hadaegh, et al.International Journal of Endocrinology and Metabolism|December 26, 2018
Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose StudyDavood Khalili, Fereidoun Azizi, Samaneh Asgari, et al.Diabetes/Metabolism Research and Reviews|January 21, 2016
Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose StudySheila Afsharian, Samaneh Akbarpour, Hengameh Abdi, et al.International Journal of Endocrinology and Metabolism|December 19, 2013
The effect of community-based education for lifestyle intervention on the prevalence of metabolic syndrome and its components: tehran lipid and glucose studyFereidoun Azizi, Parvin Mirmiran, Amir Abbas Momenan, et al.Archives of Iranian Medicine|September 8, 2020
Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion StatementMojtaba Malek, Farhad Hosseinpanah, Hamid Reza Aghaei Meybodi, et al.Nutrition & Metabolism|June 28, 2016
Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian populationZahra Ghasemzadeh, Hengameh Abdi, Samaneh Asgari, et al.Plos One|December 3, 2014
Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort studyYounes Jahangiri-Noudeh, Samaneh Akbarpour, Mojtaba Lotfaliany, et al.BMC Endocrine Disorders|February 15, 2023
Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?Davood Khalili, Marjan Khayamzadeh, Karim Kohansal, et al.Journal of Diabetes and Metabolic Disorders|January 13, 2025
Health indicators in the management of diabetes in Primary health care: Iran-package of Essential Non-communicable diseases (IraPEN) programLeila Molaeipour, Fatemeh Koohi, Afshin Ostovar, et al.Pageof 37